Skip to search formSkip to main contentSkip to account menu

A-130A

Known as: (11(2R,5S,6R),12R)-10-demethyl-19-de((tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)oxy)-12-methyl-11-O-(tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)dianemycin, A 130, A-130 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Letter submitted by various organizations to OMB requesting an extension of the public comment period regarding the Office of… 
2014
2014
The clarification of industrial wastewaters by solid–liquid separation techniques and the removal of suspended particles are the… 
2004
2004
Combined use of Bispectral Index and A-Line Autoregressive Index for assessing adequacy of analgesia in patients undergoing… 
1997
1997
When the Office of Management and Budget (OMB) Circular A-130, Management of Federal Information Resources, was updated in 1996… 
1996
1996
La FOIA (Federal Freedom of Information Act) ne force pas les agences federales a repondre aux demandes preferant une reponse… 
1995
1995
Abstract : A six-month study of the implementation of 0MB Circular A-130 in the Federal scientific and technical information… 
1975
1975
An antibiotic, A-130, was isolated from a strain identified as Streptomyces hygroscopicus, strain A-130. The antibiotic belongs…